Skip to content

Computer Vision Syndrome Visual Sequelae

Visual and Ocular Sequelae of Computer Vision Syndrome: A Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04398212
Enrollment
733
Registered
2020-05-21
Start date
2018-05-21
Completion date
2020-08-01
Last updated
2020-08-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Computer Vision Syndrome

Brief summary

the university students will respond to CVS-F3 survey form and then they will be subjected to complete ophthalmic examination and investigations

Detailed description

CVS-F3 is a survey form consisted of up to 30 questions regarding Computer Vision Syndrome (CVS) complains, thereafter a randomized sample of students will be subjected to complete ophthalmic examination including visual acuity and refractive measurements, intraocular pressure measurements, Slitlamp and fungus examinations, mfERG examinations. the sudents will be requested to decrease their screen time and the examinations will be repeated one month later.

Interventions

DIAGNOSTIC_TESTmfERG (multifocal-retinogram)

mfERG will be performed for the students to document the effect of CVS on retina

Sponsors

Sohag University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

\- University students

Exclusion criteria

* Amblyopia * Anisometropia * strabismus * Previous eye surgery

Design outcomes

Primary

MeasureTime frameDescription
visual acuity1 monthvisual changes i.e. uncorrected distance visual acuity (UDVA) and corrected distance visual acuity (CDVA) using logMAR measurements following reduction of screen time
near vision1 monthnear vision changes following reduction of screen hours using card test, near visual acuity chart and near point test while the measurements will be diopters and lines of near chart

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026